Literature DB >> 21630298

Elevated serum liver enzymes and fatty liver changes associated with long driving among taxi drivers.

Steven J Lippmann1, David B Richardson, Jiu-Chiuan Chen.   

Abstract

BACKGROUND: Previous studies suggested increased morbidities and mortalities of liver diseases in drivers.
METHODS: To examine whether driving (monthly driving distance; tenure) is associated with elevated alanine aminotransferase (ALT), aspartate aminotransferase (AST), or chronic fatty liver (FL) changes, we performed a cross-sectional, secondary analysis of the Taxi Drivers' Health Study (n = 1,355), adjusting for clinical, demographic, and lifestyle factors.
RESULTS: Prevalence of elevated ALT, elevated AST, and fatty liver changes were 22.0%, 5.1%, and 9.3%, respectively. Driving distance had a positive association with elevated ALT with a prevalence ratio of 1.35 (95% CI: 0.98, 1.89) comparing the highest versus lowest driving quartile. This association differed by alcohol use, with a corresponding prevalence ratio of 2.08 (95% CI: 1.30, 3.33) among "past/current" drinkers but no association among "never" drinkers. Similar patterns were found for AST, but estimates were less stable. We found a curvilinear response pattern for fatty liver changes; prevalence first increased with years as a taxi driver and then receded in the highest ranges of driving tenure, regardless of the alcohol history.
CONCLUSIONS: Our results provide evidence that long driving is associated with both short-term and chronic liver insults, although alcohol use appears to modify this putative effect.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21630298     DOI: 10.1002/ajim.20969

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  1 in total

1.  Early Liver and Kidney Dysfunction Associated with Occupational Exposure to Sub-Threshold Limit Value Levels of Benzene, Toluene, and Xylenes in Unleaded Petrol.

Authors:  Masoud Neghab; Kiamars Hosseinzadeh; Jafar Hassanzadeh
Journal:  Saf Health Work       Date:  2015-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.